New patent expiration for Allergan drug OZURDEX
Annual Drug Patent Expirations for OZURDEX Ozurdex is a drug marketed by Allergan and is included in one NDA. It […]
Patent Expiration
New patent expiration for Bausch drug VANOS
Annual Drug Patent Expirations for VANOS Vanos is a drug marketed by Bausch and is included in one NDA. It
New patent expiration for Takeda Pharms drug INTUNIV
Annual Drug Patent Expirations for INTUNIV Intuniv is a drug marketed by Takeda Pharms Usa and is included in one
New patent expiration for Takeda Pharms drug INTUNIV Read Post »
New patent expiration for Pfizer drug TOVIAZ
Annual Drug Patent Expirations for TOVIAZ Toviaz is a drug marketed by Pfizer and is included in one NDA. It
Drug Patent Expirations for the Week of January 1, 2023
VANOS (fluocinonide) Bausch Patent: 7,220,424 Expiration: Jan 7, 2023 See More … For more information on how DrugPatentWatch can help
Drug Patent Expirations for the Week of January 1, 2023 Read Post »
New patent expiration for NOVO drug SAXENDA
Annual Drug Patent Expirations for SAXENDA Saxenda is a drug marketed by Novo and is included in one NDA. It
New patent expiration for Novo Nordisk drug VICTOZA
Annual Drug Patent Expirations for VICTOZA Victoza is a drug marketed by Novo Nordisk Inc and is included in one
New patent expiration for Novo Nordisk drug VICTOZA Read Post »
Drug Patent Expirations for the Week of December 25, 2022
VICTOZA (liraglutide recombinant) Novo nordisk inc Patent: 8,846,618 Expiration: Dec 27, 2022 See More … For more information on how
Drug Patent Expirations for the Week of December 25, 2022 Read Post »
New patent expiration for Baudax drug ANJESO
Annual Drug Patent Expirations for ANJESO Anjeso is a drug marketed by Baudax and is included in one NDA. There
